Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D

Zoledronic acid (Zol) is a widely used intravenous aminobisphosphonate to treat both benign and malignant skeletal diseases, and bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect whose pathophysiology remains poorly understood. Vascular Endothelial Growth Factor (VEGF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellone, Federica, Catalano, Antonino, Sottile, Angelo Ruggero, Gaudio, Agostino, Loddo, Saverio, Corica, Francesco, Morabito, Nunziata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636794/
https://www.ncbi.nlm.nih.gov/pubmed/34869440
http://dx.doi.org/10.3389/fmed.2021.748438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636794/
https://www.ncbi.nlm.nih.gov/pubmed/34869440
http://dx.doi.org/10.3389/fmed.2021.748438

Ejemplares similares